Status:
COMPLETED
Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study
Lead Sponsor:
St. Erik Eye Hospital
Conditions:
Vitamin d Deficiency
Central Retinal Vein Occlusion
Eligibility:
All Genders
50-90 years
Brief Summary
Retinal vein occlusion (RVO) is a common vascular disease of the eye. Studies have shown that the risk of venous thrombosis is higher in winter so even concerning RVO. Studies have shown a possible li...
Detailed Description
The study will last one year and is expected to include 120 patients with RVO and 120 control patients. The first 10 RVO patients visiting St. Erik's Eye Hospital with disease duration of maximum 3 mo...
Eligibility Criteria
Inclusion
- Newly diagnosed central retinal vein occlusion (3 months)
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT01793181
Start Date
January 1 2013
End Date
November 1 2014
Last Update
November 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Eriks Eye Hospital
Stockholm, Stockholm County, Sweden, 11282